Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults-Reply

JAMA. 2024 Feb 27;331(8):709-710. doi: 10.1001/jama.2023.27891.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Bacterial Agents* / therapeutic use
  • Cefepime* / therapeutic use
  • Hospitalization
  • Humans
  • Infections* / drug therapy
  • Piperacillin, Tazobactam Drug Combination* / therapeutic use

Substances

  • Cefepime
  • Piperacillin, Tazobactam Drug Combination
  • Anti-Bacterial Agents